Cargando…
miR-150: targeting MLL leukemia
Autores principales: | Jiang, Xi, Chen, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717789/ https://www.ncbi.nlm.nih.gov/pubmed/23175472 |
Ejemplares similares
-
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013) -
Targeting multiple nodes of MLL complexes to improve leukemia therapy
por: Dafflon, Caroline, et al.
Publicado: (2017) -
MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?
por: Ko, Gladys Y.-P., et al.
Publicado: (2022) -
miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway
por: Xu, Dan-dan, et al.
Publicado: (2016) -
MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
por: Vargova, K, et al.
Publicado: (2017)